Gilead is buying Santa Monica biotech firm Kite Pharma for $11.9 billion Los Angeles Times Health Care Companies Lead Stocks Higher; Gas Prices Jump U.S. News & World Report Gilead just handed a revolutionary kind of cancer treatment a $12 billon endorsement Business Insider Gilead Flies Kite Pharma to the Thermosphere Bloomberg Gilead to buy Kite Pharma for about $11 billion MarketWatchFull coverage
No comments: